Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Oliver Schlager Added: 7 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more
Author(s): Andrew Goldsweig Added: 6 months ago
What are the main management recommendations from SCAI and HRS concerning left atrial appendage occlusion?In this short interview, Dr Andrew Goldsweig (Baystate Medical Center, Springfield, US) discusses the new guidelines regarding transcatheter left atrial appendage occlusion by the Society for Cardiovascular Angiography & Interventions and Heart Rhythm Society. The multidisciplinary guideline… View more
Author(s): Harriette Van Spall , Michael Andrew Borger Added: 7 months ago
ESC Congress 2025 - Dr Harriette Van Spall (McMaster University, Canada) sits down with Professor Michael Borger (University of Leipzig Heart Center, Germany), Co-Chair of the newly released 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.The new guidelines bring together the latest evidence and expert consensus on how to diagnose, evaluate, and treat patients with valvular… View more
Author(s): Lucia Mazzolai Added: 1 year ago
ESC Congress 2024 — Dr Lucia Mazzolai (Lausanne University Hospital, CH) joins us to discuss key highlights from the ESC Peripheral Arterial Disease 2024 guidelines.The new guidelines emphasise the need for holistic evaluation of peripheral arterial and aortic diseases, with diagnosis and treatment involving multidisciplinary teams and care plans considered in centres with experience of the… View more
Author(s): Joost Daemen , Added: 2 years ago
In light of the recent ESC clinical consensus statement on Renal Denervation (RDN), a significant development has occurred in the management of hypertension. The European Society of Hypertension (ESH) has officially endorsed Renal Denervation as a recommended treatment for hypertension. This marks a pivotal moment in the field of hypertension management.This broadcast features a compelling… View more
Author(s): Julia Grapsa , Vijay Kunadian , Stephan Windecker , et al Added: 7 months ago
The ESC Congress 2025 symposium, “Transforming the Care of Female and Low-Risk Younger Patients With Aortic Stenosis Through Guidelines” is now available on demand.Chaired by Prof Stephan Windecker (Bern University Hospital, Bern, Switzerland) and Prof Vijay Kunadian (Newcastle University, Newcastle-upon-Tyne, UK), this session explores evolving strategies to optimise care for women and younger… View more
Author(s): Nicolas M Van Mieghem Added: 8 months ago
In these two interviews, recorded ahead of ESC 2025, Prof Nicolas Van Mieghem (Erasmus Medical Center, Rotterdam, NL) previews the late-breaking VANTAGE trial, and also a symposium addressing new guideline updates and groundbreaking innovations in TAVI and transcatheter mitral/tricuspid interventions (TMTI), disseminating practical perspectives to support cardiologists deliver optimal care for… View more
Advancing AVR

Video Series

Author(s): Christopher M Cook , Pilar Jimenez-Quevedo , Clare Appleby , et al Added: 5 months ago
Aortic valve replacement (AVR) continues to evolve, with new evidence, technologies and guidelines shaping best practice for lifetime management. This recording of the live webinar brings together leading experts to review the valvular heart disease 2025 ESC/EACTS guidelines, explore the latest data – including on asymptomatic severe AS –and highlight the role of RESILIA tissue technology and the… View more
Author(s): Saibal Kar , Harriette Van Spall Added: 2 weeks ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more